Skip to main content

Research Repository

Advanced Search

All Outputs (5)

Gestational diabetes mellitus: are mothers being followed-up? A retrospective study (2018)
Presentation / Conference
Ward, R., Hanna, F. W., Shelley-Hitchen, A., Hodgson, E., Heald, A., Fryer, A. A., & Duff, C. J. (2018, June). Gestational diabetes mellitus: are mothers being followed-up? A retrospective study

Background Women with gestational diabetes (GDM) have an elevated risk of developing type 2 diabetes (T2DM). NICE Guidance recommends women who develop GDM are screened 6 weeks post-partum and annually thereafter. Aim To evaluate conformity to gui... Read More about Gestational diabetes mellitus: are mothers being followed-up? A retrospective study.

Real-world evidence confirms that increased blood glucose monitoring strip (BGMS) accuracy reduces glycated haemoglobin (HbA1c) variance (2018)
Presentation / Conference
HEALD, A., Livingston, M., Fryer, A., Cortes, M., Gadsby, R., Ollier, W., …Craig, J. (2018, March). Real-world evidence confirms that increased blood glucose monitoring strip (BGMS) accuracy reduces glycated haemoglobin (HbA1c) variance. Poster presented at Diabetes UK Professional Conference 2018, London ExCeL, London, UK

Aim: An in silico study has reported a link between less accurate BGMS and poorer glycaemic control, leading to significant differences in both hyper- and hypoglycaemic events. Our aim was to see if we could detect this effect of BGMS accuracy on gly... Read More about Real-world evidence confirms that increased blood glucose monitoring strip (BGMS) accuracy reduces glycated haemoglobin (HbA1c) variance.

Real-world data analysis of general practice prescribing (GPP) to highlight the growing challenges in application of appropriate medication for Type 2 diabetes (2018)
Presentation / Conference
HEALD, A., Livingston, M., Fryer, A., Cortes, M., Bien, Z., Gadsby, R., …Young, R. (2018, March). Real-world data analysis of general practice prescribing (GPP) to highlight the growing challenges in application of appropriate medication for Type 2 diabetes. Poster presented at Diabetes UK Professional Conference 2018, London ExCeL, London, UK

Objective: GP apply the wide variety of Type 2 diabetes medications at different rates. Our aim was to see if there are lessons to be learnt from analysing in detail these variations. Methods: England GPP and Quality Outcome Framework data over th... Read More about Real-world data analysis of general practice prescribing (GPP) to highlight the growing challenges in application of appropriate medication for Type 2 diabetes.